10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Investor Presentation
Receives Approval in Japan for Two-Dose Vial of KOSTAIVE®, a Self-Amplifying mRNA COVID-19 Vaccine
Announces Second Quarter 2025 Financial Update and Pipeline Progress
Shareholder votes
Announces First Quarter 2025 Financial Update and Pipeline Progress
Announces Third Quarter 2024 Financial Update and Pipeline Progress
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Amended Statement of Changes in Beneficial Ownership
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Delisting Amendment